---
title: 'Personalized care in dilated cardiomyopathy: Rationale and study design of
  the activeDCM trial'
date: '2024-07-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39010317/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240716183906&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Dilated cardiomyopathy (DCM) is a leading cause of heart
  failure, particularly in younger individuals. Low physical strength is a global
  risk factor for cardiovascular mortality, and physical activity and a healthy lifestyle
  have been shown to improve outcomes in patients with heart failure. However, inappropriate
  exercise may increase the risk of arrhythmias in certain individuals with DCM. The
  determinants for predicting individual risks in this setting are poorly understood,
  ...'
disable_comments: true
---
BACKGROUND: Dilated cardiomyopathy (DCM) is a leading cause of heart failure, particularly in younger individuals. Low physical strength is a global risk factor for cardiovascular mortality, and physical activity and a healthy lifestyle have been shown to improve outcomes in patients with heart failure. However, inappropriate exercise may increase the risk of arrhythmias in certain individuals with DCM. The determinants for predicting individual risks in this setting are poorly understood, ...